Michael Michalkiewicz obtained his Doctor of Veterinary Medicine and PhD degrees from Warsaw University in Poland. He did post-doctoral studies in neuroendocrinology and molecular biology at universities in Japan and Belgium. He had faculty positions in physiology at West Virginia University and Medical College of Wisconsin.
His research focuses on the cardiovascular diseases and genomic medicine. He has developed effective genomic approaches that led to identification of novel disease genes involved in regulation of metabolism, behavior and blood pressure. In his research, he adopted various genome-wide approaches including microarrays, epigenetic, bioinformatics, signaling pathway analysis and gene manipulation in the rat. He has reported his work at international forums and in renowned scientific journals, including Science magazine.
Currently at ARI his research makes use of the electronic medical records to facilitate more personalized therapies. For instance, he is introducing into Aurora a precision medicine platform (a Best Practice Advisory type) that will help clinicians to select a proper genetic test and subsequently prescribe the best drug available based on patient’s genetics.
He actively collaborates with Aurora physicians as well as with scientists from other institutions, including Vanderbilt and Harvard Universities, BCW, or Geisinger. His research is supported by NIH funded grants.